Bouamar Hakim, Jiang Daifeng, Wang Long, Lin An-Ping, Ortega Manoela, Aguiar Ricardo C T
Division of Hematology and Medical Oncology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Division of Hematology and Medical Oncology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA Greehey Children's Cancer Research Institute, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas, USA South Texas Veterans Health Care System, Audie Murphy VA Hospital, San Antonio, Texas, USA
Mol Cell Biol. 2015 Apr;35(8):1329-40. doi: 10.1128/MCB.01446-14. Epub 2015 Feb 2.
In biological processes, the balance between positive and negative inputs is critical for an effective physiological response and to prevent disease. A case in point is the germinal center (GC) reaction, wherein high mutational and proliferation rates are accompanied by an obligatory suppression of the DNA repair machinery. Understandably, when the GC reaction goes awry, loss of immune cells or lymphoid cancer ensues. Here, we detail the functional interactions that make microRNA 155 (miR-155) a key part of this process. Upon antigen exposure, miR-155(-/-) mature B cells displayed significantly higher double-strand DNA break (DSB) accumulation and p53 activation than their miR-155(+/+) counterparts. Using B cell-specific knockdown strategies, we confirmed the role of the miR-155 target Aicda (activation-induced cytidine deaminase) in this process and, in combination with a gain-of-function model, unveiled a previously unappreciated role for Socs1 in directly modulating p53 activity and the DNA damage response in B lymphocytes. Thus, miR-155 controls the outcome of the GC reaction by modulating its initiation (Aicda) and termination (Socs1/p53 response), suggesting a mechanism to explain the quantitative defect in germinal center B cells found in mice lacking or overexpressing this miRNA.
在生物过程中,正向和负向输入之间的平衡对于有效的生理反应和预防疾病至关重要。一个恰当的例子是生发中心(GC)反应,其中高突变率和增殖率伴随着DNA修复机制的必然抑制。可以理解的是,当GC反应出现差错时,就会导致免疫细胞丧失或淋巴癌。在此,我们详细阐述了使微小RNA 155(miR-155)成为这一过程关键部分的功能相互作用。抗原暴露后,miR-155(-/-)成熟B细胞比其miR-155(+/+)对应细胞显示出显著更高的双链DNA断裂(DSB)积累和p53激活。使用B细胞特异性敲低策略,我们证实了miR-155靶标Aicda(激活诱导的胞苷脱氨酶)在此过程中的作用,并结合功能获得模型,揭示了Socs1在直接调节B淋巴细胞中p53活性和DNA损伤反应方面以前未被认识到的作用。因此,miR-155通过调节其起始(Aicda)和终止(Socs1/p53反应)来控制GC反应的结果,这提示了一种机制来解释在缺乏或过表达这种微小RNA的小鼠中发现的生发中心B细胞的定量缺陷。